12
Views
0
CrossRef citations to date
0
Altmetric

References

  • Hess B, Lahrmann H, Urbanits S et al. Ipsilateral facial pain, masseteric atrophy and oculomotor paralysis in two patients with glioma. An overlooked syndrome? Neuro-oncology 4\(Supp1.1), 46 (2002).
  • Karadag D, Karagulle AT, Erden I, Erden A. Trigeminal nerve involvement in T-cell acute lymphoblastic leukemia: value of MR imaging. Eur. Radial. 44(1), 16–18 (2002).
  • Arruga J. Metastatic and paraneoplastic lesions of the optic nerve. Rev Neural. 31(12), 1256–1258 (2000).
  • Schocket LS, Massaro-Giordano M, Volpe NJ, Galetta SL. Bilateral optic nerve infiltration in central nervous system leukemia. Ainj Ophthalmol 135(1), 94–96 (2003).
  • Boukriche Y, Bouccara D, Cyna-Gorse F, Dehais C, Feke-Dachez M, Masson C. Sudden bilateral hearing loss disclosing meningeal carcinomatosis. Rev Neural 158(6-7), 728–730 (2002).
  • Strauss C. The facial nerve in medial acoustic neuromas. j Neurosurg. 97(5), 1083–1090 (2002).
  • Bose AK, Deodhar AP, Duncan AJ. Malignant triton tumor of the right vagus. Ann. Thorac. Surg. 74(4), 1227–1228 (2002).
  • Kan S, Ikeda T DTPA enhancement of cranial nerves on MR imaging. Neoplastic lesions. Acta Neural. Scant 100,400–406 (1999).
  • •An additional tool in identifying cranial nerve involvement in meningeal carcinomatosis.
  • Kaker W, Herrlinger U, Grönewäller E et al Ocular manifestations of primary nervous system lymphoma: what can be expected from imaging?' Neural. 249, 1713–1716 (2002).
  • •Focuses the importance of ocular involevement in primary CNS lymphoma.
  • Reyes N, Terron C, Martinez E, Zabala JA, Larrondo J. Progressive cranial nerve neuropathy secondary to a perineurial spread of a facial spindel-cell carcinoma (Polyneuropatia craneal progresiva secundaria a diseminiacion perineural de un carcinoma espinocelular facial). Neurologia (Spain) 18(2), 112–115 (2003).
  • ••Very unusual but not generally known.Cancer can spread along the peripheral nerves, in particular cranial nerves.
  • Van Gerpen JA, Dyck PJB. Cutaneous T- cell lymphoma imitating gelsolin amyloidosis. Neurology60, 861 (2003).
  • Atlas SJ, Nardin RA. Evaluation and treatment of low back pain: an evidence-based approach to clinical care. Muscle Nerve 27,265–284 (2003).
  • •Useful paper to discriminate the various sources of low back pain.
  • Perrin RG, Janjan NA, Langford LA. Spinal axis metastasis. In: Cancer of The Nervous System. Levin VA (Ed.). Churchill Livingston, NY, USA, 259–280 (1996).
  • Posner JB (Ed.). Neurologic Complications of Cancer FA Davis Company. PA, USA, 85–87 (1995).
  • Pietrangeli A, Milella M, De Marco S et al. Brachial plexus neuropathy as an unusual onset of diffuse neurolymphomatosis. Neural Sci. 21(4), 241–245 (2002).
  • Bilsky MET, Vitaz TW, Boland PJ et al Surgical treatment of superior sulcus tumors with spinal and brachial plexus involvement. I Neurosurg. 97 (Suppl. 3), 301–309 (2002).
  • Stevens MJ, Goent YM. Malignant psoas syndrome: recognition of an oncologic entity. Austmlas. Radial 34,150–154 (1990).
  • Moore KR, Blumenthal DT, Gordon Smith A, Ward JH. Neurolymphomatosis of the lumbar plexus: high resolution MR neurography findings. Neurology57,740–742 (2001).
  • Dalmau J, Graus F, Marco M. Hot and dry foot. As an initial manifestation of lumbosacral plexopathy. Neurology 39,871 (1989).
  • Grisold W, Krauseneck P, Muller B (Eds.). Practical Neurooncology (Praktische Neuroonkologfe) Springer Verlag, Vienna, Austria, NY, USA (2000).
  • Grisold W, Piza-Katzer H, Jahn R, Herczeg E. Intraneural nerve metastasis with multiple mononeuropathies. j Peripher. Nerv. Syst. 5(3), 163–167 (2000).
  • Van den Bent MJ, de Bruin HG, Beun GD, Vecht CJ. Neurolymphomatosis of the median nerve. Neumlogy45 (7), 1403-1405
  • Dominick JH, McCarthy GP, Condon F et al Atypical ganglion cell tumor of the sciatic nerve. Adh. Neuml. 59,1179–1181 (2002).
  • Misdraji J, Ino Y, Lois DN et al Primary lymphoma of peripheral nerve: report of four cases. A117. I Surg. Pathol 24(9), 1257–1265 (2002).
  • Kuntzer T, Lobrinus JA, Jancer RC et al Clinicopathological and molecular biological studies in a patient with neurolymphomatosis. Muscle Nerve 23, 1604–1609 (2000).
  • Odabasi Z, Parrot JH, Reddy VVB, Oh S. Neurolymphomatosis associated with muscle and cerebral involvement caused by natural killer cell lymphoma: a case report and review of literature. J. Periph. Nerv. Sys. 6,197–203 (2001).
  • Roux S, Grossin M, De Bandt M, Palazzo E, Vachon F, Kahn ME. Angiotropic large cell lymphoma with mononeuritis multiplex mimicking systemic vasculitis. Neural Neurosurg. P4ychiatry58(3), 363–366 (1995).
  • Clerici R, Conti G, Scarpini E et al Visual loss and enlarged extraocular muscles from metastatic signet ring carcinoma. J. Neural 248,336–338 (2001).
  • •Rarely extraocular muscles can be involved in cancer patients.
  • Britto-Babapulle F. Patients with eosinophilic fasciitis should have a bone marrow examination to identify myelodysplasia. BE Delmatol 137,316–317 (1997).
  • Quasthoff S, Hartung HP. Chemotherapy- induced peripheral neuropathy. j Neural 249,9–17 (2002).
  • •• Describes the clinical symptoms and electrophysiological findings as well as morphological changes in chemotherpeutically induced polyneuropathy. Comparison of grading scales for toxicity is useful.
  • Chaudhry V, Chaudhry M, Crawford 10, Simmons O'Brien E, Griffin JW. Toxic neuropathy in patients with pre-edsting neuropathy. Neumlogy60, 337–340 (2003).
  • •Interesting paper demonstrating the influence of pre-existing polyneuropathy on the development of a toxic neuropathy in regard to vincristin, cisplatin, paclitaxel and thalidomide. Comparatively small study but an interesting aspect, which often appears to be neglected.
  • Fazeny B, Zifko U, Meryn S, Huber H, Grisold W, Dittrich C. Vinorelbine induced neurotoxicity in patients with advanced breast cancer pretreated with paclitaxel- a Phase II study. Cancer Chemother. Phatmacol 39,150–156 (1996).
  • Giannini F, Volpi N, Rossi S et al. Thalidomide induced neuropathy-a ganglionopathy. Neurology 60,877–878 (2003).
  • Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancertreatment. Cancer 47,207–214 (1981).
  • Oken MM, Creech RII, Tormey DC et al. Toxicity and response criteria of the Eastern Co-operative Oncology group. Am. J. Clin. Oncol 5,649–655 (1982).
  • Postma TJ, Heimans JJ. Grading of chemotherapy induced peripheral neuropathy. Ann. Onco111,509–513 (2000).
  • •Important help in grading neurotoxic polyneuropathy.
  • Howard HF. Neurotoxicology of neuromuscular transmission. In: Neuromuscular Disotrlers in Clinical Practice. Katirji B, Kaminski HJ, Preston DC, Ruff RL, Shapiro B (Eds). Butterworth and Heinemann, MA, USA, 964–986 (2002).
  • Sieb JR Fluoroquinolone antibiotics block neuromuscular transmission. Neurology 50, 804–807 (1998).
  • Batchelor TT, Taylor LP, Thaler HT et al Steroid myopathy in cancer patients. Neurology48, 1234–1238 (1997).
  • •Although a classic paper, it has a high impact in daily practice, as usually steroids are given for too long and in a overly high-dose resulting in proximal myopathy.
  • Bordet R, Caron J, Destee A et al Dystrophies musculaires progressives et risques medicamenteux. Therapie 94,129–132 (1994).
  • Cirigliano G, Della RA, Tavoni A et al Polymyositis occuring during alpha-interferon treatment for malignant melanoma. kieumatol. Int. 19,65–67 (1999).
  • Koeffier HP, Haskell CM. Rhabdomyolysis as a complication of 5-azacytidine. Cancer Teat. Rep. 78,573-574 (1978).
  • Sieb JP, Gillessen T Iatrogenic and toxic myopathies. Muscle Nerve 27 (2), 142–156 (2003).
  • ••Interesting overview on toxic myopathies.Relevant for patients with cancer.
  • Hurtado J, Esbr J. Treatment of malignant hypercalcemia. Expert Opin. Pharmacother. 3(5), 521–527 (2002).
  • Antoine JC. Paraneoplastic peripheral neuropathies (French). Rev Neural (Paris) 157(12), 1557–1560 (2001).
  • Rosenfeld MR, Dalmau J. Current treatment options for paraneoplastic neurologic syndromes. CUI7: Treat. Options Neural 5,69–77 (2003).
  • Rudnicki SA, Dalmau J. Paraneoplastic syndromes of the spinal cord, nerve and muscle. Muscle Nerve 23,1800–1818 (2000).
  • Bataller L, Graus F, Dalmau J. Retinopatia paraneoplásica y anticuerpos antirrecoverina. Neuralgia Marzo. 17(3), 156 (2002). (Engl.: Paraneoplastic retinopathy and antirecoverin antibodies).
  • Kanzato N, Motomura M, Sullivan IKA et al. Lambert-Eaton myasthenic syndrome with ophthalmoplegia and pseudoblepharospasm. Muscle Nerve 22, 1727–1730 (1999).
  • •Interesting observation that may change our view on optomotor disturbances in Lambert-Eaton syndrome.
  • Kloos L, Sillevis Smitt P, Ang CW et al Paraneoplastic ophthalmoplegia and subacute motor axonal neuropathy associated with antiGQ1b antibodies in a patient with malignant glioma. j Neural. Neurosurg. Psychiatry74, 507–509 (2003).
  • Rubin DI, Kimmel DW, Cascino TL. Outcome of peroneal neuropathies in patients with systemic malignant disease. Cancer83, 1602–1606 (1998).
  • Sillevis Smitt P, Grefkens J, de Leeuw B et al Survival and outcome in 73 anti Hu positive patients with paraneoplastic encephalomyelitis/sensory neuronopathy. j Neural. 249(6), 745–753 (2002).
  • Vernino S, Adamski J, Kryzer TJ et al Neuronal nicotinic ACh receptor antibody in subacute autonomic neuropathy and cancer related syndromes. Neurology50, 1806–1813 (1998).
  • •Observation that AChR-Abs mediating fast synaptic transmission in autonomic ganglia are structurally similar to muscle AChR but contain an a-3 subunit. This serologic marker for neurologic autoimmunity may be of importance for autonomic signs in paraneoplastic disease.
  • Storstein A, Vedeler C. Neuropathy and malignancy: a retrospective survey. Nemo'. 248,322–327 (2001).
  • •Important survey by a large cancer center.
  • Camerlingo M, Nemni R, Ferraro B eta'. Malignancy and sensory neuropathy of unexplained cause: a prospective study of 51 patients. Ark Neurol 55,981–984 (1998).
  • Camdessanche JP, Antoine JC, Honnorat J et al Paraneoplastic peripheral neuropathy associated with anti Hu antibodies. Brain 125,166–175 (2002).
  • ••Overview of anti Hu-associated polyneuropathy shows interesting types of neuropathy, in particular, the demyelinating type which has not been described before.
  • Evoli A, Minisci C, DiSchino C et al Thymoma in patients with MG. Neurology 59,1844–1850 (2002).
  • Dowell JE, Moots PL, Stein RS. Myasthenia gravis after allogenic bone marrow transplantation for lymphoblastic lymphoma. Bone Marrow Transplantation 24,1359–1361 (1999).
  • AAEM quality assurance committee. Literature review of the usefulness of repetitive nerve stimulation and single fibre EMG in the electrodiagnostic evaluation of patients with suspected myasthenia gravis or Lambert-Eaton myasthenic syndrome. Muscle Nerve 24,1239–1247 (2001).
  • Liguori R,Vincent A, Clover L et al Morvan's Syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage gated potassium channels. Brain 124,2417–2426 (2001).
  • Levin MI, Mozaffar T, Taher Al-Lozi M, Pestronk A. Paraneoplastic necrotizing myopathy. Clinical and pathologic features. Neurology50,764–767 (1998).
  • •A rare muscle syndrome, perhaps often overlooked.
  • Authier FJ, Grisold W, Drlicek M, Zifko U, Gherardi RIK, Creange A. Paraneoplastic necrotizing myopathies. j Neural. Sc]. 187 (Supp 1), 383 (2001).
  • Ansevin CF, Agamandis DP Rippling muscles and myasthenia gravis with rippling muscles. Arch. Neuml 53(2), 197–199 (1996).
  • Takagi A, Kojima S, Watanabe T, Ida M, Kawagoe S. Rippling muscle syndrome preceding malignant lymphoma. Intern. Merl 41(2), 147–150 (2002).
  • Vernino S, Auger RG, Emslie-Smith AM et al Myasthenia, thymoma, presynaptic antibodies and continuum of neuromuscular hyperexcitability. Neurology 53,1233–1239 (1999).
  • Finsterer J, Wogritsch C, Pokieser P eta/Light chain myeloma with oro-pharyngeal amyloidosis presenting as bulbar paralysis. Aiuni. Sc]. 147,205–208 (1997).
  • Rosenfeld MR, Dalmau J. Paraneoplastic syndromes and motor dysfunction. In: Motor Disorders. Younger DS (Ed.). Lippincott, PA, USA 397–405 (1999).
  • •Useful differentiation of paraneoplastic motor neuron diseases.
  • Kuipers-Upmeijer J, de Jager AEJ, Hew JM, Snoeck JW, van Weerden TVV. Primary lateral sclerosis: clinical neurophysiological and magnetic resonance findings. j Neural. Neurosurg. PTchiatry71, 615–620 (2001).
  • Gordon PH, Rowland LP, Younger DS et al Lymphoproliferative disorders and motor neuron disease: an update. Neurology 48,1671–1678 (1997).
  • Randall W, Chopra R. The frequency of bleeding complications in patients with haematological malignancy following the introduction of a stringent prophylactic platelet transfusion policy. BE JI-Lematol. 118(2), 677–682 (2002).
  • Jinnai K, Hayashi Y. Hemorrhage in the oculomotor nerve as a complication of leukemia. Neumpathology 21 (3), 241–244 (2001).
  • Ryan M, Yeo S, Maguire A et al. Rhinocerebral zygomycosis in childhood acute lymphoblastic leukaemia. Eur Perliatr 160,235–238 (2001).
  • Gonzalez MI, Caballero D, Lopez C et al. Cerebral toxoplasmosis and Guillain-Barré Syndrome after allogeneic peripheral stem cell transplantation. Trampl Infect. Dis. 2(3), 145–149 (2000).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.